ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: SA-PO1125

Risk of Incident CKD Among Patients with Urolithiasis: A Nationwide Longitudinal Cohort Study

Session Information

Category: CKD (Non-Dialysis)

  • 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Authors

  • Park, Kyoung Sook, National Health Insurance Service Ilsan Hospital, Goyang, Gyeonggi-do, Korea (the Republic of)
  • Kim, Jae Young, National Health Insurance Service Ilsan Hospital, Goyang, Gyeonggi-do, Korea (the Republic of)
Background

Urolithiasis has been infrequently implicated to have a causal association with chronic kidney disease (CKD). Recently, several studies have demonstrated the relationship between urolithiasis and CKD. However, the generalizability of their results is limited. We aimed to examine the association between the long-term effects of urolithiasis and the risk of incident CKD.

Methods

From the longitudinal National Health Insurance Service data, this nationwide population-based cohort study identified 219,570 Korean adults with incident urolithiasis requiring procedural interventions and without prior kidney disease and 219,570 controls without urolithiasis matched by age and sex. The primary outcome of interest was the de novo development of CKD, defined as an estimated glomerular filtration rate <60 mL/min/1.73 m2 for at least two consecutive measurements at least 90 days apart. In the sensitivity analyses, the risk of incident CKD was further examined using the outcome defined by the newly occurring diagnostic codes indicating CKD.

Results

Over a mean follow-up of 6.0 years, 12,338 (2.8%) primary outcome events of CKD were observed, with an incidence rate of 4.6 per 1,000 person-years. Multivariable Cox analysis revealed that patients with urolithiasis were associated with a higher risk of incident CKD compared with controls, with an adjusted hazard ratio of 1.41 (95% confidence interval, 1.36–1.46). This association remained consistent across all clinically relevant subgroups and when the CKD outcome was defined based on the diagnostic codes in the sensitivity analysis.

Conclusion

In this large national cohort study, patients with urolithiasis were associated with a higher risk of incident CKD than those without urolithiasis. Further studies are warranted to establish the benefits of preventing urolithiasis in reducing CKD development.